13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)

Page 7 of 7

Page 7 of 7 – SEC Filing

SIGNATURES
After reasonable inquiry and to the best of his or its knowledge and belief, each of the following Reporting Persons certifies that the information set forth in this statement is true, complete and correct.
November 22, 2017
Tang Capital Partners, LP
By:
Tang Capital Management, LLC
By:
/s/ Kevin C. Tang
Kevin C. Tang, Manager
Tang Capital Management, LLC
By:
/s/ Kevin C. Tang
Kevin C. Tang, Manager
/s/ Kevin C. Tang
Kevin C. Tang
7

Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC)

Page 7 of 7